Le Sourd S - Search Results

1

Biomarqueurs prédictifs de réponse aux inhibiteurs de points de contrôle immuns.

Frelau A, Pracht M, Le Sourd S, Lespagnol A, Corre R, Ménard C, Tarte K, Mosser J, Edeline J. Frelau A, et al. Among authors: le sourd s. Bull Cancer. 2018 Dec;105 Suppl 1:S80-S91. doi: 10.1016/S0007-4551(18)30393-X. Bull Cancer. 2018. PMID: 30595202 Review. French.

2

Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors.

Edeline J, Crouzet L, Le Sourd S, Larible C, Brunot A, Le Roy F, Cattenoz C, Latournerie M, Gédouin D, Guillygomarc'h A, Boucher E. Edeline J, et al. Among authors: le roy f, le sourd s. Cancer Chemother Pharmacol. 2015 Jan;75(1):215-9. doi: 10.1007/s00280-014-2645-z. Epub 2014 Dec 5. Cancer Chemother Pharmacol. 2015. PMID: 25477009

3

Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolization.

Laffont S, Rolland Y, Ardisson V, Edeline J, Pracht M, Le Sourd S, Rohou T, Lenoir L, Lepareur N, Garin E. Laffont S, et al. Among authors: le sourd s. Eur J Nucl Med Mol Imaging. 2016 May;43(5):824-831. doi: 10.1007/s00259-015-3277-1. Epub 2015 Dec 19. Eur J Nucl Med Mol Imaging. 2016. PMID: 26686335

4

High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with ⁹⁰ Y-loaded glass microsphere radioembolization.

Garin E, Rolland Y, Pracht M, Le Sourd S, Laffont S, Mesbah H, Haumont LA, Lenoir L, Rohou T, Brun V, Edeline J. Garin E, et al. Among authors: le sourd s. Liver Int. 2017 Jan;37(1):101-110. doi: 10.1111/liv.13220. Epub 2016 Sep 23. Liver Int. 2017. PMID: 27514012 Free PMC article.

5

Hepatocellular carcinoma in elderly patients: challenges and solutions.

Brunot A, Le Sourd S, Pracht M, Edeline J. Brunot A, et al. Among authors: le sourd s. J Hepatocell Carcinoma. 2016 Jun 17;3:9-18. doi: 10.2147/JHC.S101448. eCollection 2016. J Hepatocell Carcinoma. 2016. PMID: 27574587 Free PMC article. Review.

6

[Implementation of a nurse-driven educational program improves management of sorafenib's toxicities in hepatocellular carcinoma].

Brunot A, M'Sadek A, Le Roy F, Duval M, Le Sourd S, Ventroux E, Crouzet L, Guillygomarc'h A, Boucher E, Lelievre N, Laguerre B, Edeline J. Brunot A, et al. Among authors: le roy f, le sourd s. Bull Cancer. 2016 Nov;103(11):941-948. doi: 10.1016/j.bulcan.2016.09.017. Epub 2016 Nov 3. Bull Cancer. 2016. PMID: 27817860 French.

7

Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study.

Viaud J, Brac C, Artru P, Le Pabic E, Leconte B, Bodère A, Pracht M, Le Sourd S, Edeline J, Lièvre A. Viaud J, et al. Among authors: le sourd s, le pabic e. Dig Liver Dis. 2017 Jun;49(6):692-696. doi: 10.1016/j.dld.2017.02.007. Epub 2017 Feb 14. Dig Liver Dis. 2017. PMID: 28256401 Free article.

8

Implementation of a Nurse-driven Educational Program Improves Management of Sorafenib's Toxicities in Hepatocellular Carcinoma.

Brunot A, Le Roy F, Le Sourd S, M'Sadek A, Duval M, Crouzet L, Guillygomarc'h A, Boucher E, Laguerre B, Edeline J. Brunot A, et al. Among authors: le roy f, le sourd s. Cancer Nurs. 2018 Sep/Oct;41(5):418-423. doi: 10.1097/NCC.0000000000000521. Cancer Nurs. 2018. PMID: 28731881

9

Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.

Palard X, Edeline J, Rolland Y, Le Sourd S, Pracht M, Laffont S, Lenoir L, Boudjema K, Ugen T, Brun V, Mesbah H, Haumont LA, Loyer P, Garin E. Palard X, et al. Among authors: le sourd s. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):392-401. doi: 10.1007/s00259-017-3845-7. Epub 2017 Nov 25. Eur J Nucl Med Mol Imaging. 2018. PMID: 29177870 Free PMC article.

10

WITHDRAWN: Biomarqueurs prédictifs de réponse aux inhibiteurs de points de contrôle immuns.

Frelau A, Pracht M, Le Sourd S, Lespagnol A, Corre R, Ménard C, Tarte K, Mosser J, Edeline J. Frelau A, et al. Among authors: le sourd s. Bull Cancer. 2018 Mar 7:S0007-4551(17)30384-3. doi: 10.1016/j.bulcan.2017.10.031. Online ahead of print. Bull Cancer. 2018. PMID: 29525053 Free article. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters